Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Food Chemistry|November 2, 2018
Effect of light intensity and processing conditions on bioactive compounds in maté extracted from yerba mate (Ilex paraguariensis A. St.-Hil.)Liza Ghassan Riachi, Daniel Luiz Reis Simas, Geraldo Ceni Coelho, et al.
International Journal of Cancer|October 8, 2021
Circulating DNA changes are predictive of disease progression after transarterial chemoembolizationDavid Sefrioui, Vincent Verdier, Céline Savoye-Collet, et al.
Health Science Reports|December 8, 2022
An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir-grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)Jean-Pierre Bronowicki, Patrick Miailhes, Bertrand Hanslik, et al.
Digestive Diseases and Sciences|January 29, 2016
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in FrancePatrick Marcellin, Fabien Zoulim, Christophe Hézode, et al.
Clinics and Research in Hepatology and Gastroenterology|April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic responseJessica Azzi, Céline Dorival, Carole Cagnot, et al.
Digestive Diseases and Sciences|April 19, 2020
Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in FranceDenis Ouzan, Dominique Larrey, Dominique Guyader, et al.
Journal of Medical Virology|November 19, 2002
HIV and HCV co-infection: situation at six French university hospitals in the year 2000Claudine Buffet-Janvresse, Hélène Peigue-Lafeuille, Jacques Benichou, et al.
Journal of Hepatology|May 25, 2019
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinomaJean-Louis Jouve, Thierry Lecomte, Olivier Bouché, et al.
European Journal of Gastroenterology & Hepatology|August 14, 2023
Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohortEric Nguyen-Khac, Pierre Nahon, Olivier Ganry, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trialMarc Bourlière, Pascaline Rabiega, Nathalie Ganne-Carrie, et al.
Pageof 5